Addex Therapeutics - ADR Financials

$3.26

$-0.22 (-6.32%)

As on 15-Sep-2026 16:00EDT

Market cap

$4 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.1

Div. Yield

0 %

Annual
Quarterly

Income Statement (CHF Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.09	0.03	0.40	1.61	1.42	2.92
Cost of Revenue	0.27	0.01	0.85	6.94	14.62	12.82
Gross Profit	-0.18	0.03	0.40	1.61	1.42	2.92
Operating Expenses	2.70	2.84	3.16	3.86	11.96	18.42
Operating Profit (EBIT)	-2.88	-2.81	-2.76	-2.24	-10.54	-15.51
Other Income	--	--	--	--	--	--
Profit before Tax	-7.54	-6.84	-4.91	-2.50	-10.80	-15.35
Provision for Tax	--	--	--	0.02	0.12	0.12
Profit after Tax (Net Income)	-7.43	-6.73	7.06	-10.56	-20.80	-15.35
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-20.80	-15.35

Liabilities (CHF Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	3.29	4.77	9.68	1.15	4.91	16.93
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.25	0.40	0.20	0.60	0.09	1.48
Current Liabilities	1.22	1.20	0.80	2.89	3.28	4.13
Total Liabilities	5.98	6.37	10.68	4.64	8.28	22.54

Assets (CHF Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	3.57	4.69	7.14	0.41	0.45	0.60
Current Assets	1.19	1.68	3.54	4.23	7.83	21.94
Total Assets	5.98	6.37	10.68	4.64	8.28	22.54
Total Debt*	0.10	0.03	0.04	0.34	0.37	0.48
Net Current Assets	-0.03	0.48	2.74	1.34	4.55	17.81

Cashflow (CHF Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-2.08	-5.37	-7.99	-16.44	-14.71
Cash Flow from Investing Activities	--	-0.65	4.65	-0.01	0.00	-0.03
Cash from Financing Activities	--	1.13	0.10	5.26	3.10	16.40
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS (CHF)	-7.22	-5.67	0.07	-13.30	-41.82	-52.97
Cash EPS (CHF)	--	-5.67	0.07	-12.92	-41.17	-51.77
Adjusted Book Value (CHF)	--	4.02	0.10	1.44	9.88	58.42
Dividend per Share (CHF)	--	--	--	--	--	--
Cash Flow per Share (CHF)	--	-1.75	-0.05	-10.07	-33.04	-50.74
Free Cash Flow per Share (CHF)	--	-1.75	-0.05	-10.08	-33.04	-50.85

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-92.67	125.89	-311.58	-183.30	-94.21
ROE (%)	-160.70	-93.16	130.39	-348.48	-190.48	-97.35
ROA (%)	-89.92	-78.95	92.11	-163.36	-134.99	-71.87
EBIT Margin (%)	-6,646.28	-22,821.86	-1,214.00	-154.77	-757.57	-524.26
Net Margin (%)	-7,936.88	-22,448.44	1,746.04	-654.47	-1,462.57	-526.42
Cash Profit Margin (%)	-0.49	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-45.62	-0.93	-0.75	0.13	-0.51	-0.19
EBIT Growth (%)	-26.93	-39.43	-96.52	76.83	29.52	-19.55
Net Profit Growth (%)	-185.68	-195.36	166.84	49.26	-35.52	-19.39
EPS Growth (%)	-159.39	-80.07	1.01	0.68	0.21	0.08
Book Value Growth (%)	-77.25	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.01	0.00	0.30	0.08	0.03
Short term debt to equity ratio	0.02	0.00	0.00	0.24	0.06	0.02
Current Ratio	0.97	1.40	4.42	1.46	2.39	5.31
Quick Ratio	0.97	--	--	--	267.95	5.31
Interest Coverage	-1,481.91	-2,825.35	-1,383.08	-115.53	-220.38	-242.63

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	34.18	67.09	3.84	9.38	42.06	11.12
Asset Turnover	0.01	0.00	0.05	0.25	0.09	0.14
Receivable days	--	217.05	75.37	84.87	118.47	24.60
Inventory Days	--	--	--	-45,902.13	-10,885.03	2.32
Payable days	--	15,340.34	264.58	59.53	38.26	39.48
Cash Conversion Cycle	--	--	--	-45,876.79	-10,804.82	-12.56

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.